Afinitor (Everolimus) Combo For Breast Cancer Approved By FDA

[News]

The FDA has approved Afinitor (everolimus) in combination with Aromasin (exemestane) for the treatment of some postmenopausal females with advanced hormone-receptor positive, HER2-negative breast cancer...

More... (http://www.medicalnewstoday.com/articles/248144.php)